China Resources Land (01109) accumulated contract sales of approximately 70.0 billion yuan in the first four months, representing a year-on-year growth of 2.2%.
China Resources Land (01109) announced that as of April 30, 2026, the company and its subsidiaries (the Group) achieved a total contract sales amount of approximately RMB 25.88 billion and a total contract sales area of approximately 594,000 square meters in the past month, representing a year-on-year increase of 49.6% and a decrease of 0.1%, respectively. The cumulative contract sales amount for the first four months of 2026 amounted to approximately RMB 70.00 billion, with a total contract sales area of approximately 1.843 million square meters, representing a year-on-year increase of 2.2% and a decrease of 28.4%, respectively.
CHINA RES LAND (01109) announcement, for the month ending on April 30, 2026, the total contract sales amount achieved by the company and its subsidiaries (the Group) is approximately RMB 25.88 billion, with a total contracted sales area of approximately 594,000 square meters, representing a year-on-year increase of 49.6% and a decrease of 0.1% respectively.
For the first four months of 2026, the cumulative contract sales amount is approximately RMB 70.0 billion, with a total contracted sales area of approximately 1.843 million square meters, representing a year-on-year increase of 2.2% and a decrease of 28.4% respectively.
In April 2026, the Group's recurring income is approximately RMB 4.23 billion, with a year-on-year growth of 7.0%. Among them, the rental income from operating real estate leasing business is approximately RMB 2.85 billion, with a year-on-year growth of 11.3%.
For the first four months of 2026, the cumulative recurring income is approximately RMB 17.57 billion, with a year-on-year growth of 7.4%. Among them, the rental income from operating real estate leasing business is approximately RMB 12.0 billion, with a year-on-year growth of 13.3%.
Related Articles

ZYLOXTB(02190) spent approximately HKD 1.1362 million to repurchase 51,000 shares on May 12th.

PW MEDTECH (01358) spent 992,000 Hong Kong dollars to repurchase 841,000 shares on May 12th.

CIG Shanghai (06166) will distribute a final dividend of $0.28 per share on June 25th.
ZYLOXTB(02190) spent approximately HKD 1.1362 million to repurchase 51,000 shares on May 12th.

PW MEDTECH (01358) spent 992,000 Hong Kong dollars to repurchase 841,000 shares on May 12th.

CIG Shanghai (06166) will distribute a final dividend of $0.28 per share on June 25th.

RECOMMEND

Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026

HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026

The Chip Stock Frenzy Is Still Accelerating
11/05/2026


